At least $4,055 in Oakhurst Medicaid payments tied to COVID-19 services in 2024

Data from the U.S. Department of Health and Human Services Medicaid Provider Spending database shows that Medicaid payments in Oakhurst in 2024 reached at least $4,055 for services coded specifically for COVID-19.

Medicaid is a public insurance program managed by the states and supported by both federal and state governments. It serves low-income people and families, seniors, children, and individuals with disabilities, making it a significant part of the U.S. health care system.

As Medicaid funding comes from taxpayers, fluctuations in local billing reveal how public health care resources are spent within communities.

This analysis used HCPCS codes classified as “COVID-19” or “coronavirus”-related in billing details or reference files to identify COVID-related services. Therefore, totals only include services directly tagged as COVID-related and do not account for pandemic care billed under broader codes.

Comparatively, Clifton had the highest Medicaid payments for COVID-19–related services reported in New Jersey for 2024, totaling $1,725,516.

The only provider to submit Medicaid claims for COVID-19–related services in Oakhurst in 2024 was Genesis Laboratory Management, LLC, according to the data.

During the pandemic, spending on COVID-19–specific services drove much of the increase in Oakhurst’s overall Medicaid expenditures.

Total Medicaid spending across other claim types rose by $951,961 from 2020 to 2024, a 132% climb.

In the two years prior to the pandemic, average yearly Medicaid payments in Oakhurst were $1,296,408.

According to the Centers for Medicare & Medicaid Services, combined federal and state Medicaid spending was about $871.7 billion in fiscal year 2023, making up roughly 18% of national health expenses—rising from $613.5 billion in 2019, before the COVID-19 pandemic began.

This change represents a nearly 40% increase over several years, primarily fueled by higher enrollment and greater utilization during and after the pandemic.

Recent federal budget acts introduced during the Trump administration proposed significant reductions to Medicaid funding and possible restructuring. The “One Big Beautiful Bill Act,” enacted in 2025, is slated to cut over $1 trillion from federal Medicaid support over 10 years, introducing work requirements and extra cost-sharing measures that could restrict coverage and funding for some recipients. These adjustments are projected to increase states’ funding responsibilities and may contain the rate of growth in federal Medicaid while the program covers tens of millions nationwide.

Note: Includes HCPCS codes specifically marked for COVID-19 services; these totals do not capture all pandemic-related health spending.

This article used data from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Find the original dataset here.